Since we have recently published that the crizotinib sensitivity in NB cells is linked to the crizotinib—ALK binding22, we performed the cellular thermal shift assay (CETSA), a method shown to be useful in quantifying drug-target interactions35–37. This evidence concerns the gene ALK and neuroblastoma.